PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
Synapse
⌘+K
Synapse
June 13, 2026CancersOpen Access

Advances in Precision Diagnostics and Personalized Therapeutics for Prostate Cancer: An Integrated Precision Continuum from Risk-Adapted Detection to Biomarker-Directed Therapy and Dynamic Monitoring

View Full Paper
Ask AI
Bookmark
Share

Authors

TNTakahide NoroTUTakanobu UtsumiRIRino Ikeda

Discussion

Loading...

Member takes

Overview

Narrative review synthesizes evidence on precision diagnostics and therapies for prostate cancer, suggesting key strategies for improved patient outcomes.

Key Points

  • The aim is to provide an integrated overview of precision diagnostics and personalized therapies in prostate cancer management.
  • Narrative review of contemporary clinical guidelines and diagnostic strategies for prostate cancer.
  • Evaluation of risk-adapted detection, multimodal diagnosis, and biomarker application.
  • Analysis of longitudinal monitoring approaches including liquid biopsies and AI-enabled pathology.
  • Use of polygenic risk scores improves identification of clinically significant prostate cancer while reducing overdiagnosis risks.
  • MRI-first pathways effectively reduce unnecessary biopsies while ensuring critical disease detection.
  • Implementation of standardized reporting enhances multidisciplinary communication and treatment planning.

Cite This Study

Noro et al. (2026) studied this question.

synapsesocial.com/papers/6a2cf488faef96ed7f056c63https://doi.org/10.3390/cancers18121909
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Precision Diagnostics in Prostate Cancer: Integrating Biomarkers, Imaging, Genomics, and Artificial Intelligence in Contemporary United States Practice2026
  2. 2Integrative advances in biomarker-driven prostate cancer management from genomic discovery to precision oncology2026
  3. 3Next-Generation Precision Oncology in Prostate Cancer: Synergistic Liquid Biopsy, mpMRI, and AI-Guided Multi-Omics Strategies2026
  4. 4Redefining Prostate Cancer Precision: Radiogenomics, Theragnostics, and AI-Driven Biomarkers2025 · 4 citations
  5. 5Genomic landscape and precision therapy in prostate cancer: current status and future directions2026